New tools for studying protein movements and structures
DEER spectroscopy tools for probing protein conformational dynamics
This study is working on new ways to use a special technique called DEER spectroscopy to better understand how proteins move and change, which is important for figuring out diseases and helping with drug development.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11019798 on NIH RePORTER |
What this research studies
This research focuses on developing innovative methods for DEER spectroscopy, a technique that allows scientists to observe and quantify the movements and structures of proteins at a very small scale. By combining experimental techniques with advanced computational methods, the project aims to improve the analysis of protein dynamics, which are essential for understanding various biological processes and diseases. The research will also explore new ways to label proteins in their natural environments, enhancing the accuracy of the findings. Overall, this work seeks to provide valuable insights that could aid in drug development and other biomedical applications.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions related to protein misfolding or dysfunction, such as certain genetic disorders or neurodegenerative diseases.
Not a fit: Patients with conditions unrelated to protein dynamics or those who do not have access to advanced biostructural analysis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding of protein dynamics, potentially resulting in more effective drug therapies.
How similar studies have performed: Previous research has shown success in using advanced spectroscopy techniques to study protein dynamics, indicating that this approach has the potential for significant breakthroughs.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Stoll, Stefan — University of Washington
- Study coordinator: Stoll, Stefan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.